| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/31/1996 | EP0723460A1 Gene therapy of the nervous system |
| 07/31/1996 | EP0723455A1 Methods of inhibiting phagocytosis |
| 07/31/1996 | EP0723440A1 Therapeutic delivery compositions and methods of use thereof |
| 07/31/1996 | EP0723402A1 Senescent cell-derived inhibitors of dna synthesis |
| 07/31/1996 | EP0550665B1 Novel neurothrophic factor |
| 07/25/1996 | WO1996022373A2 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma |
| 07/25/1996 | WO1996022368A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/25/1996 | WO1996022277A1 Nitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their production |
| 07/25/1996 | WO1996022112A1 Delivery of therapeutic agents by gene therapy |
| 07/25/1996 | WO1996022101A1 Combined therapeutical treatment of hyperproliferative diseases |
| 07/25/1996 | WO1996006177A3 Retrovirus-like particles made non-infectious by a plurality of mutations |
| 07/25/1996 | CA2210718A1 Delivery of therapeutic agents by gene therapy |
| 07/25/1996 | CA2210618A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/25/1996 | CA2210347A1 Nitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their production |
| 07/25/1996 | CA2210158A1 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma |
| 07/24/1996 | EP0722738A2 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations |
| 07/24/1996 | EP0722496A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 07/24/1996 | EP0722452A1 Nf-at polypeptides and polynucleotides |
| 07/24/1996 | EP0722343A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 07/24/1996 | EP0722342A1 REGULATION OF bcl-2 GENE EXPRESSION |
| 07/24/1996 | EP0722334A1 Therapeutic treatment for inhibiting blood vessel blockage using a polypeptide |
| 07/24/1996 | EP0722331A1 Method for producing a highly enriched population of hematopoietic stem cells |
| 07/24/1996 | EP0722330A1 Methods for analysis of human stem cells |
| 07/24/1996 | EP0722318A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 07/24/1996 | EP0722275A1 Cell death regulator |
| 07/24/1996 | CN1127532A Method for diagnosing a disorder by determining expression of GAGE tumor rejection antigen precursors |
| 07/24/1996 | CN1127527A Ribozyme gene therapy for HIV infection and Aids |
| 07/24/1996 | CA2140814A1 Use of calreticulin in modulating hormone responsiveness and new pharmaceuticals for treating cancer, osteoporosis and chronic inflammatory disease |
| 07/23/1996 | US5539082 Peptide nucleic acids |
| 07/23/1996 | US5538866 Immunoassay; medical diagnosis |
| 07/23/1996 | US5538854 Method for the determination of predisposition to autoimmune disease |
| 07/23/1996 | US5538722 Isolation, growth, differentiation and genetic engineering of human muscle cells |
| 07/18/1996 | WO1996021736A1 Human geranylgeranyl pyrophosphate synthetase |
| 07/18/1996 | WO1996021734A2 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/18/1996 | WO1996021733A2 Transfert of dna in cells with the view to correcting the adrenoleucodystrophy |
| 07/18/1996 | WO1996021732A1 Il-2r-associated polypeptide and dna molecules coding therefor |
| 07/18/1996 | WO1996021731A2 Stabilized external guide sequences |
| 07/18/1996 | WO1996021471A1 Compositions and methods for treating tumor cells |
| 07/18/1996 | WO1996021470A2 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy |
| 07/18/1996 | WO1996021416A2 Methods and compositions for treatment of solid tumors in vivo |
| 07/18/1996 | WO1996021356A1 Methods and compositions for inducing mucosal immune responses |
| 07/18/1996 | WO1996016163A3 Embryonal cardiac muscle cells, their preparation and their use |
| 07/18/1996 | WO1996009399A3 Chimeric adenovirus for gene delivery |
| 07/18/1996 | WO1996006860A3 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 07/18/1996 | WO1995034669A3 Retroviral gene therapy vectors and therapeutic methods based thereon |
| 07/18/1996 | WO1995033062A3 Method for introducing foreign matter into higher eukaryotic cells |
| 07/18/1996 | CA2210132A1 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy |
| 07/18/1996 | CA2209990A1 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/18/1996 | CA2209989A1 Compositions and methods for treating tumor cells |
| 07/18/1996 | CA2209064A1 Methods and compositions for inducing mucosal immune responses |
| 07/17/1996 | EP0721510A1 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 07/17/1996 | EP0721503A1 USING ANTISENSE OLIGONUCLEOTIDES TO MODULATE NERVE GROWTH AND TO REVERSE $g(b)/A4 AMYLOID-INDUCED MORPHOLOGY |
| 07/17/1996 | EP0721351A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response |
| 07/17/1996 | EP0721350A1 Intracellular immunization |
| 07/17/1996 | EP0721341A1 Cloning and characterization of the complete mage-1 gene |
| 07/17/1996 | EP0638121B1 Targeted cleavage of rna using eukaryotic ribonuclease p and external guide sequence |
| 07/11/1996 | WO1996021035A2 Retroviral delivery of full length factor viii |
| 07/11/1996 | WO1996021026A1 POLYMERASE δ MUTATIONS IN COLORECTAL TUMORS WITH REPLICATION ERRORS |
| 07/11/1996 | WO1996021020A2 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 07/11/1996 | WO1996021015A2 Combination gene delivery vehicles |
| 07/11/1996 | WO1996021014A2 Production and administration of high titer recombinant retroviruses |
| 07/11/1996 | WO1996021007A2 Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells |
| 07/11/1996 | WO1996020954A2 Functionally active domains of signal transducer and activators of transcription (stat) proteins |
| 07/11/1996 | WO1996020733A1 Treatment of tumors by transduction with negative selective markers, application of interaction agents and subsequent radiation exposure |
| 07/11/1996 | WO1996020732A2 Non-traumatic administration of gene delivery vehicles |
| 07/11/1996 | WO1996020731A1 Direct administration of gene delivery vehicles at multiple sites |
| 07/11/1996 | WO1996020723A1 Controlling traf-mediated signals |
| 07/11/1996 | WO1996020721A1 Programmed cell death genes and proteins |
| 07/11/1996 | WO1996020698A2 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | WO1996012508A3 Combined use of nucleoside analogues and gene transfection for tissue imaging and therapy |
| 07/11/1996 | CA2209604A1 Functionally active domains of signal transducer and activators of transcription (stat) proteins |
| 07/11/1996 | CA2209526A1 Programmed cell death genes and proteins |
| 07/11/1996 | CA2209226A1 Polymerase .delta. mutations in colorectal tumors with replication errors |
| 07/11/1996 | CA2207974A1 Treatment of tumors by transduction with negative selective markers, application of interaction agents and subsequent radiation exposure |
| 07/11/1996 | CA2207961A1 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | CA2205871A1 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 07/10/1996 | EP0720652A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 07/10/1996 | EP0666929A4 Method of inhibiting replication of hyperproliferative cells. |
| 07/10/1996 | CN1126093A Medical carrier of protein coat for carrying gene and its prodn. method |
| 07/04/1996 | WO1996020280A1 Isolated polysialyl transferases, nucleic acid molecules coding therefor, methods of production and use |
| 07/04/1996 | WO1996020279A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases |
| 07/04/1996 | WO1996020277A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
| 07/04/1996 | WO1996020219A2 Murine monoclonal anti-idiotype antibody 3h1 |
| 07/04/1996 | WO1996020207A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
| 07/04/1996 | WO1996020014A1 Viral vector complexes having adapters of predefined valence |
| 07/04/1996 | WO1996020013A1 Improvements in or relating to endometrial function |
| 07/04/1996 | WO1996020011A1 Chemical compounds |
| 07/04/1996 | WO1996019965A2 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 07/04/1996 | CA2208719A1 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 07/04/1996 | CA2208706A1 Mutants of the rb and p53 genes and uses thereof |
| 07/04/1996 | CA2208502A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases |
| 07/04/1996 | CA2208446A1 Improvements in or relating to endometrial function |
| 07/04/1996 | CA2208291A1 Isolated polysialyl transferases, nucleic acid molecules coding therefor, methods of production and use |
| 07/04/1996 | CA2205091A1 Chemical compounds |
| 07/03/1996 | EP0719343A1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/03/1996 | EP0719332A1 Monocyte macrophage line recombinant cells for gene therapy |
| 07/03/1996 | EP0719328A1 Grb3-3 gene, variants and uses thereof |
| 07/03/1996 | EP0719147A1 Gene therapy for solid tumors, papillomas and warts |
| 07/02/1996 | US5532220 Of mammarian cancer cells lacking endogeneous protein; introducing suppressor gene encoding protein into cells |
| 07/02/1996 | US5532143 Isolated DNA molecules for intergration site independent gene expression in mammalian host cells |